312 related articles for article (PubMed ID: 27132152)
21. Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation.
Li J; Zhang J; Shi Y; Sievert H; Taub CC; Bertog S; Ta S; Changhui L; Senser E; Wang J; Hu R; Huang J; Ruan F; Han Y; Li X; Wang B; Zhao X; Liu J; Hsi DH; Liu L
Heart; 2023 Jan; 109(4):289-296. PubMed ID: 36270787
[TBL] [Abstract][Full Text] [Related]
22. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation.
Kwon DH; Kapadia SR; Tuzcu EM; Halley CM; Gorodeski EZ; Curtin RJ; Thamilarasan M; Smedira NG; Lytle BW; Lever HM; Desai MY
JACC Cardiovasc Interv; 2008 Aug; 1(4):432-8. PubMed ID: 19463341
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
Seggewiss H; Faber L
Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
[TBL] [Abstract][Full Text] [Related]
26. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
[TBL] [Abstract][Full Text] [Related]
27. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
Veselka J
Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
[TBL] [Abstract][Full Text] [Related]
28. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
29. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
30. Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
Bogachev-Prokophiev AV; Afanasyev AV; Zheleznev SI; Pivkin AN; Fomenko MS; Sharifulin RM; Karaskov AM
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1536-1542.e2. PubMed ID: 28947201
[TBL] [Abstract][Full Text] [Related]
31. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
32. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
Zeng Z; Wang F; Dou X; Zhang S; Pu J
Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
[TBL] [Abstract][Full Text] [Related]
33. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients?
Cooper RM; Shahzad A; McShane J; Stables RH
J Invasive Cardiol; 2015 Jul; 27(7):301-8. PubMed ID: 26136275
[TBL] [Abstract][Full Text] [Related]
34. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.
Sathyamurthy I; Nayak R; Oomman A; Subramanyan K; Kalarical MS; Mao R; Ramachandran P
Indian Heart J; 2014; 66(1):57-63. PubMed ID: 24581097
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
Gross CM; Schulz-Menger J; Krämer J; Siegel I; Pilz B; Waigand J; Friedrich MG; Uhlich F; Dietz R
J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
[TBL] [Abstract][Full Text] [Related]
36. Transluminal percutaneous septal myocardial ablation in a patient with hypertrophic obstructive cardiomyopathy.
Tsuchikane E; Nakamura T; Yamazaki K; Kitano K; Izumi M; Otsuji S; Tateyama H; Awata N; Sakurai M; Kobayashi T
Jpn Circ J; 1998 Jul; 62(7):537-40. PubMed ID: 9707012
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in childhood.
Emmel M; Sreeram N; deGiovanni JV; Brockmeier K
Z Kardiol; 2005 Oct; 94(10):699-703. PubMed ID: 16200487
[TBL] [Abstract][Full Text] [Related]
38. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society.
Faber L; Seggewiss H; Gietzen FH; Kuhn H; Boekstegers P; Neuhaus L; Seipel L; Horstkotte D
Z Kardiol; 2005 Aug; 94(8):516-23. PubMed ID: 16049653
[TBL] [Abstract][Full Text] [Related]
39. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
[TBL] [Abstract][Full Text] [Related]
40. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
